Shanghai, China
Specialized in tumor immunopharmacology and preclinical pharmacodynamic research, with a proven track record in end-to-end project delivery for global oncology drug R&D，as well as IND projects. Responsible for cross-border client communication, research protocol formulation, quotation provision and on-schedule delivery of research reports for tumor immunology-related drug pharmacology and pharmacodynamics studies. Led and oversaw multiple pharmacodynamic validation and PKPD (Pharmacokinetic-Pharmacodynamic) projects, ensuring strict adherence to study objectives and timelines. Possess years of hands-on experience in molecular biology experiments, with proficiency in operating dozens of bioinformatics software tools for data analysis and study design. Expert in designing experimental protocols for in vivo pharmacology, pharmacodynamics and pharmacokinetic studies, with a solid command of various statistical analysis methods to ensure the scientific rigor of research results.
Deeply engaged in the fields of tumor immunopharmacology and preclinical pharmacodynamic research, with a well-demonstrated track record in end-to-end delivery of global oncology drug R&D projects and Investigational New Drug (IND) applications. Leveraging profound professional accumulation, I provide core technical support and full-cycle solutions for global oncology drug research and development initiatives. Possess years of in-depth practical experience in molecular biology experiments, oversee multiple pharmacodynamic validation and Pharmacokinetic-Pharmacodynamic (PKPD) integration research projects for tumor immunology-related drugs, including overall coordination of cross-border client communication and in-depth engagement.
1.Led the optimization of R&D processes and product registration projects for early-stage colorectal cancer screening products; also responsible for chronic disease risk prediction and personalized dietary guidance research based on bioinformation analysis. 2.Complete R&D and registration-related experiments as scheduled, and organize the compilation and submission of registration dossiers for innovative medical product applications. For the registration of early colorectal cancer screening products, took charge of experimental design, on-site experimental operation, and partial drafting of official registration dossiers; coordinated cross-team communication on experimental design, data analysis and research report writing to ensure seamless project progress. 3.Served as the Project Leader for the chronic disease risk prediction program, overseeing the full-cycle R&D process including study design, experimental implementation, data analysis and result summary.